(Q36273192)

13 August 2017

1 reference

title

Oncogenes as novel targets for cancer therapy (part III): transcription factors (English)

1 reference

13 August 2017

5

Ruiwen Zhang

1 reference

13 August 2017

3

Elizabeth R Rayburn

1 reference

13 August 2017

6

Hui Wang

1 reference

13 August 2017

Zhuo Zhang

1

1 reference

13 August 2017

Mao Li

series ordinal

2

1 reference

13 August 2017

Donald L Hill

series ordinal

4

1 reference

13 August 2017

publication date

1 January 2005

1 reference

Molecular Diagnosis and Therapy

13 August 2017

published in

1 reference

13 August 2017

volume

5

1 reference

13 August 2017

issue

5

1 reference

13 August 2017

page(s)

327-338

1 reference

https://scigraph.springernature.com/pub.10.2165/00129785-200505050-00005

13 August 2017

exact match

0 references

cites work

E2F1 has both oncogenic and tumor-suppressive properties in a transgenic model

1 reference

https://api.crossref.org/works/10.2165%2F00129785-200505050-00005

Nuclear cathepsin B-like protease cleaves transcription factor YY1 in differentiated cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00129785-200505050-00005

HOXB7 expression is regulated by the transcription factors NF-Y, YY1, Sp1 and USF-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00129785-200505050-00005

Enhancer-promoter activity of human papillomavirus type 16 long control regions isolated from cell lines SiHa and CaSki and cervical cancer biopsies.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00129785-200505050-00005

Cloning of the novel human myeloid-cell-specific C/EBP-epsilon transcription factor

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00129785-200505050-00005

10.2165/00129785-200505050-00005

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

13 August 2017

1003722039

0 references

1 reference